Eur J Pediatr. 2026 Nov 18;185(12):949. doi: 10.1007/s00431-026-07634-7.
ABSTRACT
Neonatal shock is associated with a high case fatality rate. Detection and management of shock by monitoring only clinical parameters may be inadequate due to inconsistent association with tissue perfusion. We evaluated the efficacy of adding functional echocardiography to standard clinical assessment in improving short-term outcome in neonates with shock. This was an open-labelled randomized clinical trial conducted in level III NICU of a tertiary care hospital in India. Neonates born at 28-42 completed weeks of gestation and developing shock defined by presence of at least two of seven prespecified criteria: tachycardia, hypotension, prolonged capillary refilling time, low perfusion index, increased central-to-peripheral temperature difference, oliguria and metabolic acidosis were randomized into two groups: Echo group-shock managed using both standard clinical assessment and functional echocardiography and, Clinical group- shock managed using only standard clinical assessment. Primary outcome was survival without inotropic support at 72 h post-randomization. Secondary outcomes were time to hemodynamic stability, survival to discharge and severe intraventricular hemorrhage or cystic periventricular leukomalacia. Baseline characteristics were largely comparable in the two groups. Survival without inotropic support at 72 h was observed in 28 (73.7%) of 38 neonates in the Echo group and 13 (33.3%) of 39 neonates in the Clinical group (RR, 2.21; 95% CI, 1.36-3.58, P = 0.0004; adjusted RR, 2.18; 95% CI, 1.33-3.59). Hemodynamic stability was reached earlier in the Echo group (median, 3 vs. 5 h; P = .001). Survival to discharge (73.7% vs. 59.0%; RR, 1.25; 95% CI, 0.90-1.73) and severe intraventricular hemorrhage or cystic periventricular leukomalacia (10.5% vs. 7.7%) did not differ significantly.
CONCLUSIONS: In this single-center, open-label trial, adding protocolized functional echocardiography to clinical assessment increased survival without inotropic support at 72 h after randomization. Survival to discharge and severe brain injury did not differ significantly; the trial was not powered for these outcomes. Multicenter trials with blinded outcome assessment are needed.
TRIAL REGISTRATION: Clinical Trial Registry of India Identifier (CTRI/2023/08/056672), registered on 21st august 2023.
WHAT IS KNOWN: • Diagnosis of neonatal shock and initiating inotropes solely on the basis of clinical parameters like low BP or isolated tachycardia does not address the underlying physiology. • This practice may not help match the pharmacological action of drug to underlying cause.
WHAT IS NEW: • In a randomized trial of neonates with shock, adding protocolized functional echocardiography to clinical assessment increased survival without inotropic support at 72 h (74% vs. 33%). • Effects on survival to discharge (74% vs. 59%) and severe brain injury were imprecise; multicenter trials are needed before routine use.
PMID:43052408 | DOI:10.1007/s00431-026-07634-7
